Literature DB >> 23219999

Complex roles of caspases in the pathogenesis of inflammatory bowel disease.

Christoph Becker1, Alastair J Watson, Markus F Neurath.   

Abstract

Caspases are cysteine proteases that regulate embryonic development, cell differentiation, tissue homoeostasis, and removal of damaged and harmful cells from the intestine and other parts of the body. Caspase activity is mainly regulated at the posttranslational level, which allows their rapid activation and response to cellular stress and pathogenic stimuli. In most cell types, caspases are initially expressed as inactive proenzymes, which undergo proteolytic cleavage to become functional enzymes. Caspase dysfunction has been associated with intestinal diseases, including inflammatory bowel disease (IBD) and colorectal cancer. Although the roles of caspases have been studied extensively in regulation of apoptosis, recent discoveries have highlighted cell death-independent functions of this protein family. In particular, caspase-1, caspase-4, caspase-5, and caspase-12 are activated during innate immune responses and participate in the formation of the inflammasome. Caspase-8 controls necroptosis of Paneth cells and potentially the death of intestinal epithelial cells in patients with Crohn's disease and appears to be involved in mucosal inflammation. Regulators of caspase-8 might therefore be used to prevent cell death in patients with IBD. Improving our understanding of the regulation and function of caspases in the intestine might lead to new therapeutics for chronic intestinal inflammation and inflammation-associated cancer.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219999     DOI: 10.1053/j.gastro.2012.11.035

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  Beta-7 integrin controls enterocyte migration in the small intestine.

Authors:  Elke Kaemmerer; Paula Kuhn; Ursula Schneider; Thomas Clahsen; Min Kyung Jeon; Christina Klaus; Julia Andruszkow; Michael Härer; Sabine Ernst; Angela Schippers; Norbert Wagner; Nikolaus Gassler
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

2.  Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.

Authors:  Xiaorong Zhu; Jeannette S Messer; Yunwei Wang; Fanfei Lin; Candace M Cham; Jonathan Chang; Timothy R Billiar; Michael T Lotze; David L Boone; Eugene B Chang
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 3.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

4.  Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles.

Authors:  Jingyao Mu; Xiaoying Zhuang; Qilong Wang; Hong Jiang; Zhong-Bin Deng; Baomei Wang; Lifeng Zhang; Sham Kakar; Yan Jun; Donald Miller; Huang-Ge Zhang
Journal:  Mol Nutr Food Res       Date:  2014-05-19       Impact factor: 5.914

Review 5.  Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.

Authors:  Bruno Christian Koehler; Dirk Jäger; Henning Schulze-Bergkamen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

6.  Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.

Authors:  Stephanie N Spohn; Francesca Bianco; Rachel B Scott; Catherine M Keenan; Alisha A Linton; Conor H O'Neill; Elena Bonora; Michael Dicay; Brigitte Lavoie; Rebecca L Wilcox; Wallace K MacNaughton; Roberto De Giorgio; Keith A Sharkey; Gary M Mawe
Journal:  Gastroenterology       Date:  2016-07-29       Impact factor: 22.682

7.  Intestinal genetic inactivation of caspase-8 diminishes migration of enterocytes.

Authors:  Elke Kaemmerer; Paula Kuhn; Ursula Schneider; Min Kyung Jeon; Christina Klaus; Miriam Schiffer; Danika Weisner; Christian Liedtke; Jörg Jäkel; Lieven Nils Kennes; Ralf-Dieter Hilgers; Norbert Wagner; Nikolaus Gassler
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.

Authors:  Honggang Wang; Jianning Dong; Peiliang Shi; Jianhui Liu; Lugen Zuo; Yi Li; Jianfeng Gong; Lili Gu; Jie Zhao; Liang Zhang; Wei Zhang; Weiming Zhu; Ning Li; Jieshou Li
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 9.  Genetics of inflammatory bowel disease from multifactorial to monogenic forms.

Authors:  Anna Monica Bianco; Martina Girardelli; Alberto Tommasini
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

10.  Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense.

Authors:  Kara G Lassen; Petric Kuballa; Kara L Conway; Khushbu K Patel; Christine E Becker; Joanna M Peloquin; Eduardo J Villablanca; Jason M Norman; Ta-Chiang Liu; Robert J Heath; Morgan L Becker; Lola Fagbami; Heiko Horn; Johnathan Mercer; Omer H Yilmaz; Jacob D Jaffe; Alykhan F Shamji; Atul K Bhan; Steven A Carr; Mark J Daly; Herbert W Virgin; Stuart L Schreiber; Thaddeus S Stappenbeck; Ramnik J Xavier
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.